Close Menu

Beckman Coulter

Robert Friel today denied a report that the company is seeking a buyer after failing to land Beckman Coulter.

Shares of PerkinElmer climbed more than 9 percent on Thursday after a report was published saying that the firm is exploring being bought out amid a failed bid to acquire Beckman Coulter.

The company, which is being purchased by Danaher, did not report its earnings for the fourth quarter, but based on what it had previously reported for the first three quarters, revenues for the final quarter of 2010 were $986.5 million.

At the Association for Mass Spectrometry's Applications to the Clinical Lab meeting this week, proteomics researchers highlighted the need for higher-throughput assays, with several introducing automated SISCAPA workflows employing instruments from vendors including Agilent Technologies and Thermo Fisher Scientific.

The action is an amendment to a lawsuit in which plaintiffs argued that the company, its board, and certain of its officers breached their fiduciary duty in connection to the company's trouble with its Accutn1 troponin test last year.

Beckman Coulter said that it's board of directors will pay a quarterly dividend of $.19 per share.

Today's announcement ends two months of speculation about the future of Beckman Coulter as Danaher continues to add to its life sciences tools portfolio.

Wayne Cowens joined NanoString from Genomic Health this week, while Roche proposed new members for its board of directors, and BioNanomatrix hired Erik Holmlin as its new CEO; and more.

The announcement follows developments last year in which next-gen sequencing uncovered fragments of a porcine circovirus within a rotavirus vaccine, prompting the US Food and Drug Administration to consider the use of sequencing as a quality-control measure for vaccines and biologics.

Its time estimate is based on the current status of its clinical trial for the test, including site and patient enrolment, and preliminary myocardial infarction incidence rates observed.

Pages

A genetic genealogy analysis helped secure the release of a California man from prison after getting his murder conviction overturned, the Guardian reports.

Technology Review discusses the concerns that come along with the ability to quickly synthesize viruses like SARS-CoV-2.

Researchers have uncovered large bacteriophages whose genomes include translational machinery, Live Science reports.

In PNAS this week: role for Myc in alternative splicing regulation in prostate cancer, variation in methylation in Arabidopsis, and more.